| New Anti-Anxiety Drug Starts a Clinical Phase II in Generalized Anxiety Disorders |
|
| Written by Administrator | |
|
Abiogen Pharma today announced the start of a Phase II clinical trial in Vienna (Austria) in patients affected by GAD with ABIO 08/01, a new anti-anxiety drug. (full story ) |
| < Prev | Next > |
|---|
| Related Resources |
|---|
